NotesFAQContact Us
Collection
Advanced
Search Tips
Showing all 2 results Save | Export
Venlafaxine ER for the Treatment of Pediatric Subjects with Depression: Results of Two Placebo-Controlled Trials
Peer reviewed Peer reviewed
Direct linkDirect link
Emslie, Graham J.; Findling, Robert L.; Yeung, Paul P.; Kunz, Nadia R.; Li, Yunfeng – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
Objective: The safety, efficacy, and tolerability of venlafaxine extended release (ER) in subjects ages 7 to 17 years with major depressive disorder were evaluated in two multicenter, randomized, double-blind, placebo-controlled trials conducted between October 1997 and August 2001. Method: Participants received venlafaxine ER (flexible dose,…
Descriptors: Safety, Patients, Adolescents, Suicide
Youth Risk Behavior Surveillance--Selected Steps Communities, United States, 2007 and Youth Risk Behavior Surveillance--Pacific Island United States Territories, 2007. Morbidity and Mortality Weekly Report. Surveillance Summaries. Volume 57, Number SS-12
PDF on ERIC Download full text
Shaw, Frederic E., Ed. – Centers for Disease Control and Prevention, 2008
The "Morbidity and Mortality Weekly Report" ("MMWR") Series is prepared by the Centers for Disease Control and Prevention (CDC). Data in the weekly "MMWR" are provisional, based on weekly reports to CDC by state health departments. This issue of "MMWR" contains the following studies: (1) Youth Risk Behavior…
Descriptors: Death, Heart Disorders, Acquired Immunodeficiency Syndrome (AIDS), Sexually Transmitted Diseases